Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a copy of the newspaper advertisement published on August 11, 2020, giving notice of hearing of the petition filed before the National Company Law Tribunal, Mumbai Bench (''Tribunal'') for sanction of the Scheme of Amalgamation of Arrow Remedies Private Limited and Fagris Medica Private Limited and Strides Emerging Markets Limited ('Transferor Companies') with Strides Pharma Science Limited ('Transferee Company') and their respective Shareholders and Creditors. The petition is fixed for hearing before the Tribunal on August 24, 2020. The above is for your information and records.
11-08-2020

Buy Strides Pharma; target of Rs 650: Motilal Oswal

 Motilal Oswal is bullish on Strides Pharma recommended buy rating on the stock with a target price of Rs 650 in its research report dated August 06, 2020.
07-08-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement published on August 6, 2020, in the 'Financial Express' and 'Lokmat' newspaper providing Extract of Unaudited Financial Results of the Company for the quarter ended June 30, 2020. Kindly take the same on record.
06-08-2020
Bigul

We are looking at vaccines as new growth pivot: Strides Pharma chief

 In a Q&A, pharma major's MD & CEO, R Ananthanarayanan says the firm is setting up a vaccine suite and is in final-stage talks with global players to seal a deal for developing a Covid-19 vaccine
05-08-2020

Earnings Call Transcript - Q1FY21 for Strides Pharma Science

 Conference Call with Strides Pharma Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.
05-08-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 The Board of Directors of the Company in their meeting held today have allotted 25,600 equity shares of face value of Rs. 10/- each to the eligible employees who have exercised their stock options under Strides ESOP 2016 Plan. These shares shall rank in pari passu with the existing equity shares of the Company in all respects. Consequent to above, the paid-up share capital of the Company has increased from Rs. 89,56,76,640/- consisting of 8,95,67,664 equity shares of Rs. 10/- each to Rs. 89,59,32,640/- consisting of 8,95,93,264 equity shares.
05-08-2020
Bigul

Strides Pharma Science Ltd - 532531 - Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2020

 We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2020, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 12:30 hrs and concluded at 13:20 hrs. This is for your information and record.
05-08-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 We write to inform that the Company shall host its earnings call with analysts and investors on Wednesday, August 5, 2020, at 17:15 hrs IST to discuss the un-audited financial results of the Company for the quarter ended June 30, 2020.
04-08-2020
Bigul

Strides Pharma Science (455.1): Buy

 The stock of Strides Pharma Science gained 4.3 per cent with above average volume, surpassing the immediate resistance at 435. Investors with a short
03-08-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 This has reference to our letter dated July 29, 2020 relating to intimation of Board Meeting scheduled to be held on Wednesday, August 5, 2020 to consider and approve the Unaudited Financial Results (Standalone and Consolidated basis) for the quarter ended June 30, 2020. In compliance with Regulation 30 and 47 of SEBI Listing Regulations, please find enclosed copies of newspaper advertisements published in Business Standard (English Edition) and Lokmat (Marathi Edition), both dated July 30, 2020. This is for your information and records.
30-07-2020
Next Page
Close

Let's Open Free Demat Account